Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
The ONTARGET Investigators
- 31 Mar, 2008
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
